KOSPI · Healthcare · ₩456B
₩8,380+1.58%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 9.1% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“이번 분기, 매출은 늘었지만 이익 회복이 다음 관문이에요.”
In the company's words · 2026 2분기 filing